IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion ...

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced it has entered into a strategic partnership with ...

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies.

Funding awarded by UKRI to explore sustainable manufacturing of new targeted radiotherapy treatments that could improve ...

A groundbreaking study led by Nobel Laureate David Baker and Timothy Patrick Jenkins introduces innovative, computationally ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

With the advent of machine learning and artificial intelligence, materials science could be poised to take its next big leap ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...

The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional antivenoms fail.

A partnership with biotechnology firm Illumina Inc. aims to unlock insights from genomics data by combining Illumina’s ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.